17α-Hydroxyprogesterone Powder (68-96-2) video
17α-Hydroxyprogesterone Powder (68-96-2) Specification:
|Chemical Structure:||Product Name: 17α-Hydroxyprogesterone|
|Cas No.: 68-96-2|
|Molecular Formula: C21H30O3|
|Molecular Weight: 330.46|
|Storage: Dry, dark· and at 0 – 4 C for short term (days to weeks) or -20 C for long term (months to years).|
|Documents(COA & HPLC etc.): Available|
17α-Hydroxyprogesterone Powder (68-96-2) Description:
17A-Hydroxyprogesterone is a metabolite of progesterone. It serves as an intermediate in the biosynthesis of hydrocortisone and gonadal steroid hormones.
Hydroxyprogesterone has been used prophylactically for the 12th to 37th week of pregnancy, particularly in women who are in the high-risk category for premature delivery . A concern relating to teratogenic potential has limited its use. Hydroxyprogesterone as a tocolytic agent requires further evaluation .
- 1: Ambroziak U, Bednarczuk T, Ginalska-Malinowska M, Małunowicz EM, Grzechocińska B, Kamiński P, Bablok L, Przedlacki J, Bar-Andziak E. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency – management in adults. Endokrynol Pol. 2010 Jan-Feb;61(1):142-55. Review. PubMed PMID: 20205117.
- 2: Ambroziak U, Bednarczuk T, Ginalska-Malinowska M, Małunowicz EM, Grzechocińska B, Kamiński P, Bablok L, Przedlacki J, Bar-Andziak E. [Congenital adrenal hyperplasia due to 21-hydroxylase deficiency–management in adults]. Endokrynol Pol. 2010;61 Suppl 1:7-21. Polish. PubMed PMID: 22127631.
- 3: Choi JH, Kim GH, Seo EJ, Kim KS, Kim SH, Yoo HW. Molecular analysis of the AR and SRD5A2 genes in patients with 46,XY disorders of sex development. J Pediatr Endocrinol Metab. 2008 Jun;21(6):545-53. PubMed PMID: 18717241.
PRECAUTION AND DISCLAIMER:
This Material is Sold For Research Use Only. Terms of Sale Apply. Not for Human Consumption, nor Medical, Veterinary, or Household Uses.